HIMS vs TDOC

Hims & Hers retains growth potential driven by its D2C telehealth platform and positioning in chronic care like GLP-1s, evidenced by 59% YoY FY25 revenue growth and 2.5 million subscribers. However, the investment thesis for 10x growth within 3-5 years has significantly weakened since the last analysis. Intensified regulatory pressure on compounded GLP-1s directly threatens its fastest-growing seg...

Teladoc Health operates in a vast and growing virtual care market, with a clear strategic vision centered on whole-person health and employer/payer partnerships, offering significant long-term potential (24/30). Financial discipline shows incremental improvement, focusing on cost controls and a clearer path to adjusted profitability, helping stabilize cash burn, but GAAP profitability remains elus...